Skip to main content
. 2022 Mar 30;25(4):662–677. doi: 10.1089/jpm.2021.0578

Table 2.

General Quality Assessment Summary: Review Authors' Judgments for Each Study

Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Overall score, % Qualitya
Wu and Koo7 2 2 1 2 2 0 0 2 1 2 2 2 2 2 79 Moderate
Kwan et al.31 2 2 1 1 2 2 2 2 2 2 2 2 1 1 86 High
Ayyari et al.35 2 1 1 2 2 1 0 2 2 2 1 1 1 1 68 Moderate
Mok et al.32 2 2 1 2 2 0 0 2 2 2 1 1 1 1 68 Moderate
Stinson and Kirk40 2 2 1 1 2 0 0 2 1 2 1 1 1 1 61 Moderate
Musarezaie et al.37 2 1 1 2 2 2 0 1 1 2 1 2 1 1 68 Moderate
Babamohamadi et al.36 2 2 1 2 2 0 1 2 2 2 1 2 2 2 82 High
Wang et al.33 2 2 1 2 2 0 0 2 2 2 1 2 1 1 71 Moderate
Butts6 2 2 1 1 2 0 0 1 1 2 1 2 1 1 61 Moderate
Pramesona et al.34 2 2 1 2 0 0 0 2 2 2 2 1 2 2 71 Moderate
Ichihara et al.25 2 2 1 2 0 0 0 2 2 2 1 2 2 2 71 Moderate
Elham et al.3 2 2 1 2 0 0 0 2 2 2 1 1 1 1 61 Moderate
Alp and Yucel2 2 2 1 2 1 0 0 2 2 2 1 2 1 1 68 Moderate
Zhang et al.30 2 2 1 1 0 2 0 1 2 2 1 1 2 2 68 Moderate
Carvalho et al.38 2 2 1 1 NA NA NA 1 1 2 1 1 1 1 64 Moderate
Vlasblom et al.39 2 1 1 2 NA NA NA 1 2 2 1 1 1 1 68 Moderate

Studies were scored using the Standard Quality Assessment Criteria for Evaluating Primary Research Articles developed by the Alberta Heritage Foundation for Medical Research.28 Score: yes (2 points), partial (1 point), no (0 points), or NA (not applicable). Q1, question/objective; Q2, design; Q3, method of subject/comparison group; Q4, subject characteristics; Q5, intervention and random allocation; Q6, blinding of investigators; Q7, blinding of subjects; Q8, outcome(s)/robust measurement; Q9, sample size; Q10, analytic methods; Q11, estimate of variance (e.g., confidence intervals, standard errors); Q12, controlled for confounding; Q13, results reported; Q14, conclusions supported by the results.

a

Quality of each study as low if the overall score is below 60%, moderate if the overall score is between 60% and 79%, and high if it is above 80%.